A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: Investigating mechanisms of pathogenesis

Clinical and Experimental Immunology

Volumn 160, Issue 3, 2010, Pages 340-347

  Freimanis, G ^b   Hooley, P ^a   Ejtehadi, H Davari ^c   Ali, H A ^b   Veitch, A ^b   Rylance, P B ^b   Alawi, A ^e   Axford, J ^e   Nevill, A ^a   Murray, P G ^d   Nelson, P N ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

^c BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Autoimmunity; Retrovirus; Rheumatology; Virus

Indexed keywords

AUTOANTIGEN; CYTOKINE; EPITOPE; GAG PROTEIN; MESSENGER RNA;

ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL CULTURE; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; RHEUMATOID ARTHRITIS; RNA EXTRACTION; SEROLOGY; SYNOVIOCYTE; SYNOVIUM; UPREGULATION;

EID: 77952172555     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04110.x     Document Type: Article

References (40)

1. Ejtehadi HD, Freimanis GL, Ali HA et al. The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study. Ann Rheum Dis 2006 65 : 612 616.
2. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001 409 : 860 921. (Pubitemid 32165345)
3. Nelson PN, Carnegie PR, Martin J et al. Demystified. Human endogenous retroviruses. Mol Pathol 2003 56 : 11 18.
4. Boller K, Schonfeld K, Lischer S et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 2008 89 : 567 572. (Pubitemid 351622454)
5. Michaels FH, Banks KL, Reitz MS Jr. Lessons from caprine and ovine retrovirus infections. Rheum Dis Clin North Am 1991 17 : 5 23.
6. Herrmann M, Neidhart M, Gay S, Hagenhofer M, Kalden JR. Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 1998 10 : 347 354. (Pubitemid 28421250)
7. Nelson PN, Lever AM, Smith S et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999 28 : 277 289. (Pubitemid 29372699)
8. Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD, Mehraein Y. Human endogenous retrovirus HERV-K (HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol 2006 33 : 16 23. (Pubitemid 43054274)
9. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 324.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162 : 156 159. (Pubitemid 17064313)
11. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981 78 : 3824 3828.
12. Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974 185 : 862 864.
13. Janin J. Surface and inside volumes in globular proteins. Nature 1979 277 : 491 492.
14. Bhaskaran R, Ponnuswamy PK. Positional flexibilities of amino-acid residues in globular-proteins. Int J Peptide Protein Res 1988 32 : 241 255.
15. Kaur H, Raghava GP. A neural-network based method for prediction of gamma-turns in proteins from multiple sequence alignment. Protein Sci 2003 12 : 923 929. (Pubitemid 36505427)
16. Saha S, Raghava GPS. BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. Artificial Immune Systems, Proc 2004 197 204. (Pubitemid 39750334)
17. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990 35 : 161 214. (Pubitemid 20126875)
18. Westwood OM, Hay FC, eds. Epitope mapping, 1st edn.
19. Douvas A, Takehana Y, Ehresmann G, Chernyovskiy T, Daar ES. Neutralization of HIV type 1 infectivity by serum antibodies from a subset of autoimmune patients with mixed connective tissue disease. AIDS Res Hum Retroviruses 1996 12 : 1509 1517. (Pubitemid 26366909)
20. Ivanov VS, Suvorova ZK, Tchikin LD, Kozhich AT, Ivanov VT. Effective method for synthetic peptide immobilization that increases the sensitivity and specificity of ELISA procedures. J Immunol Methods 1992 153 : 229 233.
21. Phumoonna T, Muscatello G, Chicken C et al. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals. J Vet Med B Infect Dis Vet Public Health 2006 53 : 126 132.
22. Shamsuddin AM, Harris CC. Improved enzyme immunoassays using biotin-avidin-enzyme complex. Arch Pathol Lab Med 1983 107 : 514 517.
23. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005 204 : 55 73. (Pubitemid 40460493)
24. Contreras-Galindo R, Kaplan MH, Leissner P et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 2008 82 : 9329 9336.
25. Hahn S, Ugurel S, Hanschmann KM et al. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses 2008 24 : 717 723. (Pubitemid 351748779)
26. Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992 5 (Suppl. A 363 371.
27. Andras C, Csiki Z, Ponyi A, Illes A, Danko K. Paraneoplastic rheumatic syndromes. Rheumatol Int 2006 26 : 376 382. (Pubitemid 43318313)
28. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006 18 : 129 134. (Pubitemid 43740384)
29. Racanelli V, Prete M, Minoia C, Favoino E, Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 2008 7 : 352 358.
30. Moyes D, Griffiths DJ, Venables PJ. Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet 2007 23 : 326 333. (Pubitemid 46978355)
31. Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 1998 20 : 5 22.
32. Routsias JG, Tzioufas AG, Moutsopoulos HM. The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 2004 340 : 1 25.
33. Haraguchi S, Good RA, Day-Good NK. A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways. Immunol Res 2008 41 : 46 55. (Pubitemid 351903813)
34. Mameli G, Astone V, Arru G et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 2007 88 : 264 274. (Pubitemid 46085138)
35. Sicat J, Sutkowski N, Huber BT. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol 2005 32 : 1821 1831. (Pubitemid 41324826)
36. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001 15 : 579 589. (Pubitemid 33016443)
37. Brudek T, Christensen T, Hansen HJ, Petersen T, Moller-Larsen A. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients. Scand J Immunol 2008 67 : 295 303. (Pubitemid 351197168)
38. Sawada S, Takei M. Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmun Rev 2005 4 : 106 110. (Pubitemid 40255618)
39. Nellaker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 2006 3 : 44. (Pubitemid 47202078)
40. Brudek T, Luhdorf P, Christensen T, Hansen HJ, Moller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J Neuroimmunol 2007 187 : 147 155. (Pubitemid 47001539)